Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
29,626 total articles
BioAge Labs shares plunged more than half in pre-market trading after Novo Nordisk announced that ziltivekimab did not reduce major adverse cardiovascular events versus placebo in the Phase 3 ZEUS study. The result, seen despite evidence the drug suppressed the IL-6 pathway, has direct implications for BioAge's lead program BGE-102, an NLRP3 inhibi…
Morgan Stanley trimmed its full-year China GDP forecast by 20 basis points to 4.6% after June activity expanded 4.3%, missing both consensus and Beijing's target. The bank pointed to decelerating infrastructure spending after front-loading, weaker refining and petrochemical output tied to oil prices, and subdued consumption driven by fading trade-i…
Bank of America analysts argue that forward-looking inflation metrics have become the primary barometer of Federal Reserve credibility following recent comments from Fed leadership that markets are effectively tightening policy. BofA singles out the 5-year, 5-year forward breakeven inflation rate as the Fed's preferred market-based read, notes rece…
Futures linked to Canada’s main equity gauge inched higher on Friday as investors absorbed a heavy calendar of corporate results and positioned for upcoming domestic GDP figures. Strength in metal mining names, a rebound in U.S. technology and ongoing commodity swings underpinned the moves, while traders continued to weigh the Federal Reserve’s pol…
Goldman Sachs says European companies are topping earnings forecasts in the current reporting season, with roughly two-thirds of the STOXX Europe 600 having reported. Aggregate earnings-per-share surprises are running near 3%, and first-half EPS is tracking about 13% year-over-year - the fastest pace in three years. Sector revisions have mostly tre…
Boston Scientific shares were down 0.4% in pre-market trade as the company extends losses following its Q2 2026 results released two days earlier. While revenue and adjusted EPS beat consensus, management trimmed full-year adjusted EPS and net sales growth guidance for the second straight quarter, citing an unexpected drop in U.S. WATCHMAN stand-al…
AbbVie shares fell sharply in pre-market trading after the company released second-quarter 2026 results and reiterated guidance that came in below Wall Street expectations. A previously disclosed $291 million IPR&D and milestones charge that trims EPS by $0.17 per share, combined with adjusted Q2 EPS guidance beneath consensus, prompted a class…
AbbVie narrowed its 2026 adjusted earnings forecast to reflect the planned $10.9 billion acquisition of Apogee Therapeutics, while reporting second-quarter results that exceeded analyst estimates thanks to robust sales of immunology medicines. The company expects the Apogee transaction to lower 2026 earnings by $0.14 per share and still delivered q…
Barclays strategists say that as bond market volatility increases and long-duration supply expands, corporate earnings will need to do more to underpin equity prices. The firm points to higher oil, uncertainty over the Federal Reserve's reaction function after Fed Chair Warsh's comments, and heavy capex from hyperscalers as drivers of recent market…
Eaton Corporation PLC rallied in pre-market trade after reporting second-quarter 2026 results that outpaced analyst forecasts on both earnings and revenue, and after issuing third-quarter adjusted EPS guidance above consensus. Management’s continued pattern of conservative targets, ongoing portfolio changes, and broad market strength combined to pu…
Clariant AG shares climbed after the company reported second-quarter results that exceeded analyst forecasts, coupled with a court ruling that dismissed a sizeable damages claim. The combination of stronger-than-expected adjusted EBITDA and sales, higher cost-savings targets and above-target free cash flow underpinned investor confidence and lifted…
Novo Nordisk shares dropped sharply in pre-market trading after its IL-6 inhibitor ziltivekimab failed to lower major adverse cardiovascular events in the Phase 3 ZEUS trial. The hazard ratio versus placebo was 0.99 across more than 6,300 patients. The result removes an anticipated pipeline catalyst and follows a court decision allowing a sharehold…
U.S. equity futures rose as investor optimism around artificial intelligence spending strengthened demand for technology and semiconductor stocks following a robust cloud update from Amazon. Major movers included Amazon, which jumped after reporting its strongest cloud revenue growth in over four years and disclosing a $25 billion annual run rate f…
Rocket Lab shares advanced in pre-market trading after the company signed a third consecutive multi-launch agreement with Japanese synthetic aperture radar operator iQPS for three more dedicated Electron launches. The deal raises iQPS's total Electron missions to 18 and comes as analysts maintain bullish ratings and investors position ahead of Rock…
U.S. equity mutual funds and ETFs recorded net inflows in the week through July 29, driven by renewed interest in mega-cap technology names following robust earnings from Microsoft and Amazon. The $11.83 billion of net purchases into U.S. equities more than offset the $10.68 billion pulled over the prior two weeks, while flows into bond funds slowe…
Novo Nordisk shares plunged after the company disclosed that its experimental IL-6 inhibitor ziltivekimab did not reduce major adverse cardiovascular events (MACE) in the Phase 3 ZEUS trial. While the drug hit biological targets by lowering free IL-6 and high-sensitivity C-reactive protein, the study produced a hazard ratio of 0.99 (95% CI: 0.88 to…
Cboe Global Markets posted a sizable second-quarter profit increase driven by a surge in options trading amid elevated market volatility. The firm recorded strong growth in options revenue and overall net revenue, supported by record U.S. options volumes and a single-day contract peak during a sharp market sell-off. Cboe's market position in retail…
Walmart-owned Flipkart has struck a partnership with Netflix to provide Flipkart Plus loyalty members with a 30-day Netflix Mobile subscription when they make four qualifying orders in a calendar month. The promotion, starting Aug. 1, applies across Flipkart's marketplace, Flipkart Grocery and Flipkart Minutes as the company leverages loyalty incen…
Marvell Technology shares jumped in pre-market trading after Amazon disclosed that AWS has reached $25 billion in annual revenue driven by its custom AI chips and Microsoft reported rapid data center expansion tied to its Maia 200 accelerator. Investors interpreted those announcements as direct demand signals for Marvell, which supplies key network…
Nextpower surged in pre-open trading after reporting first-quarter fiscal 2027 results that substantially beat Wall Street expectations. Adjusted EPS and revenue topped forecasts by wide margins, while gross margins expanded and backlog surpassed $5.5 billion. The company also closed an acquisition to strengthen inverter capabilities and retains a …
Newell Brands stock climbed 15.7% in pre-market trading after the company reported second-quarter 2026 adjusted EPS of $0.42, more than double the Wall Street consensus of $0.19, and revenue of $2.0 billion, slightly above expectations. A $126 million pretax tariff recovery and a marked upgrade to full-year guidance helped drive the move, alongside…
Cohu's stock spiked in pre-market trading after the semiconductor test equipment maker reported a sizable beat on second-quarter 2026 earnings and revenue, raised its HPC revenue outlook for the year, and issued Q3 guidance implying strong year-over-year growth. Analysts raised price targets and the broader market's positive tone helped lift invest…
MediaTek's board has authorized a discretionary financing envelope of $5 billion to back long-term expansion, notably its effort to supply custom AI chips for cloud data centers. The company raised its 2027 addressable market estimate for custom AI chips to $80 billion and increased its target share, while outlining production and revenue milestone…
Moderna fell sharply in pre-open trading after announcing that its norovirus vaccine candidate mRNA-1403 failed to meet early success criteria in a Phase 3 interim analysis. The disappointment came despite second-quarter revenue that topped consensus, and was compounded by a roughly $0.9 billion charge to 2026 cost of sales tied to litigation and a…
Telus shares tumbled sharply in pre-market trading after the company reported Q2 2026 results and announced a 55% cut to its quarterly dividend, removal of a dividend reinvestment plan discount, a revenue guidance downgrade, and a three-point strategic plan under incoming CEO Victor Dodig aimed at accelerating debt reduction and refocusing capital …
